ASCO: Controversies in Phase I Clinical Trials

August 12, 2011
Steve Joffe, MD
Steve Joffe, MD

Steve Joffe, MD discusses the ethical challenges and controversies in phase I clinical cancer trials.

Steve Joffe, MD discusses the ethical challenges and controversies in phase I clinical cancer trials: how physicians should present these clinical trials to patients-phase I trials typically have very low response rates (5% to 10%)-and explain their purpose without exaggerating the likely results.